Centre for Life Course Health Research, University of Oulu, Oulu, Finland.
Centre for Life Course Health Research, University of Oulu, Oulu, Finland; Biocenter Oulu, University of Oulu, Oulu, Finland; Department of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London, United Kingdom.
Psychiatry Res. 2019 Sep;279:186-194. doi: 10.1016/j.psychres.2019.02.060. Epub 2019 Mar 12.
There is limited knowledge available on the association of vitamin D with psychiatric disorders in young adults. We aimed to investigate vitamin D levels and associating factors in schizophrenia, other psychoses and non-psychotic depression. We studied 4,987 participants from the Northern Finland Birth Cohort 1966 (31 years) with available serum 25-hydroxyvitamin D [25(OH)D] measurements. The final sample was divided into four groups: schizophrenia (n = 40), other psychoses (n = 24), non-psychotic depression (n = 264) and control (n = 4659). To account for the influence of environmental and technical covariates, we generated a vitamin D score variable with correction for season, sex, batch effect and latitude. We further examined how vitamin D levels correlate with anthropometric, lifestyle, socioeconomic and psychiatric measures. Neither serum 25(OH)D concentration nor vitamin D score differed between schizophrenia, other psychoses, non-psychotic depression and control group. The prevalence of vitamin D deficiency was 3.2%, insufficiency 25.5%, and sufficiency 71.3%. Low vitamin D score correlated with regular smoking in the group with schizophrenia. No difference was observed in other psychiatric conditions. We did not find any difference in vitamin D status between schizophrenia, psychoses, non-psychotic depression and control groups, but future studies are warranted to elucidate the role of vitamin D in psychiatric conditions.
目前关于维生素 D 与青年期精神障碍之间关联的知识有限。我们旨在调查精神分裂症、其他精神病和非精神病性抑郁症患者的维生素 D 水平及其相关因素。我们研究了来自 1966 年芬兰北部出生队列的 4987 名参与者(31 岁),他们有可用的血清 25-羟维生素 D [25(OH)D] 测量值。最终样本分为四组:精神分裂症(n=40)、其他精神病(n=24)、非精神病性抑郁症(n=264)和对照组(n=4659)。为了考虑环境和技术协变量的影响,我们生成了一个维生素 D 评分变量,对季节、性别、批次效应和纬度进行了校正。我们进一步研究了维生素 D 水平与人体测量、生活方式、社会经济和精神科测量值之间的相关性。血清 25(OH)D 浓度和维生素 D 评分在精神分裂症、其他精神病、非精神病性抑郁症和对照组之间均无差异。维生素 D 缺乏症的患病率为 3.2%,不足为 25.5%,充足为 71.3%。低维生素 D 评分与精神分裂症组中规律吸烟有关。在其他精神病状况中未观察到差异。我们未发现精神分裂症、精神病、非精神病性抑郁症和对照组之间的维生素 D 状态存在差异,但需要进一步研究阐明维生素 D 在精神疾病中的作用。